Journal of Neurovirology

Article	Citations
COVID-19 and the nervous system	140
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19	101
Peripheral facial nerve palsy associated with COVID-19	92
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients	89
Neurological manifestations of COVID-19: available evidences and a new paradigm	66
Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2	50
COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review	44
Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19	43
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?	39
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature	39
Coronaviruses and the central nervous system	38
Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells	35
Pseudorabies virus encephalitis in humans: a case series study	34
A COVID-19 patient with intense burning pain	30
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease	29
Magnetic resonance imaging features of COVID-19-related cranial nerve lesions	29
A case report of simultaneous autoimmune and COVID-19 encephalitis	28
Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia	25
Lifetime antiretroviral exposure and neurocognitive impairment in HIV	25
Meningoencephalitis associated with COVID-19: a systematic review	24
Neurological features and outcome in COVID-19: dementia can predict severe disease	24
Concurrent tonic pupil and trochlear nerve palsy in COVID-19	24
Cognitive dysfunction following COVID-19 infection	23
Potential mechanisms of cerebrovascular diseases in COVID-19 patients	23
Optic neuritis following SARS-CoV-2 infection	23

Determinants of neurological syndromes caused by varicella zoster virus (VZV)	22
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs	21
Ageusia and anosmia, a common sign of COVID-19? A case series from four countries	21
Neurocognitive impairment and gray matter volume reduction in HIV-infected patients	20
Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research	18
Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients	18
The “Three Italy” of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia	16
Comparison of tick-borne encephalitis between children and adults—analysis of 669 patients	15
Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV	14
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus	14
Beta-amyloid (Aβ) uptake by PET imaging in older HIV+ and HIV- individuals	14
Collateral damage: Impact of SARS-CoV-2 pandemic in people living with HIV	14
COVID-19: update of the Italian situation	14
Neuropathies and neurological dysfunction induced by coronaviruses	14
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study	13
A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series	13
Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system	13
Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host	13
Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab	13
The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation	12
HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil	12
Neurological disease caused by Oropouche virus in northern Brazil: should it be included in the scope of clinical neurological diseases?	12
MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?	12
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system	12
“Anosmia” the mysterious collateral damage of COVID-19	12
Intersecting roles of ER stress, mitochondrial dysfunction, autophagy, and calcium homeostasis in HIV-associated neurocognitive disorder	11
Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV	11
Guillain-Barré syndrome associated with COVID-19: a case report study	11
Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals	11
The association of peripheral immune markers with brain cortical thickness and surface area in South African people living with HIV	11
Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data	11
Accelerated epigenetic aging in adolescents living with HIV is associated with altered development of brain structures	10
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology	10
Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease	10
Clinical and magnetic resonance imaging patterns of extensive Chikungunya virus–associated myelitis	10
Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2	10
Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses	10
Low levels of frailty in HIV-positive older adults on antiretroviral therapy in northern Tanzania	10
Investigation of simian virus 40 (SV40) and human JC, BK, MC, KI, and WU polyomaviruses in glioma	9
Molecular epidemiology of enteroviruses and predominance of echovirus 30 in an Iranian population with aseptic meningitis	9
A case of trigeminal neuralgia developing after a COVID-19 vaccination	9
Changes in functional connectivity in people with HIV switching antiretroviral therapy	9
The intracellular DNA sensors cGAS and IFI16 do not mediate effective antiviral immune responses to HSV-1 in human microglial cells	9
Clinical spectrum and prognosis of neurological complications of reactivated varicella-zoster infection: the role of immunosuppression	9
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature	9
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment	8
Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis	8
A human-derived 3D brain organoid model to study JC virus infection	8
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2	8
Endoplasmic reticulum stress and autophagy in HIV-1-associated neurocognitive disorders	8

HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis	8
CD8+ T cells in the central nervous system of mice with herpes simplex infection are highly activated and express high levels of CCR5 and CXCR3	8
Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report	8
Spontaneous subarachnoidal hemorrhage in patients with Covid-19: case report	8
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study	8
Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection	7
Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration	7
Middle cerebral artery ischemic stroke and COVID-19: a case report	7
Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran	7
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review	7
Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis	7
Neurological manifestations of COVID-19: with emphasis on Iranian patients	7
S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV	7
Zika virus infection in chemosensory cells	7
Varicella-Zoster Virus infected human neurons are resistant to apoptosis	7
Evidence for a novel subcortical mechanism for posterior cingulate cortex atrophy in HIV peripheral neuropathy	7
Detection of SARS-coronavirus-2 in the central nervous system of patients with severe acute respiratory syndrome and seizures	7
Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic	7
Hypoactivation in the precuneus and posterior cingulate cortex during ambiguous decision making in individuals with HIV	7
Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV	7
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders	6
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report	6
Acute viral encephalitis associated with human parvovirus B19 infection: unexpectedly diagnosed by metagenomic next-generation sequencing	6
Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study	6
Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment	6
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use	6
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells	6
The increased intrathecal expression of the monocyte-attracting chemokines CCL7 and CXCL12 in tick-borne encephalitis	6
Gut microbiota dysbiosis is associated with worse emotional states in HIV infection	6
Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression	6
Illuminating the in vitro effects of Epstein-Barr virus and vitamin D on immune response in multiple sclerosis patients	6
The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects	6
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR	6
Differential regulation of TREM2 and CSF1R in CNS macrophages in an SIV/macaque model of HIV CNS disease	6
Limbic encephalitis in a COVID-19 patient?	6
Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil	6
Rates of cognitive impairment in a South African cohort of people with HIV: variation by definitional criteria and lack of association with neuroimaging biomarkers	6
Neuroinflammation associates with antioxidant heme oxygenase-1 response throughout the brain in persons living with HIV	6
Protein LY6E as a candidate for mediating transport of adeno-associated virus across the human blood-brain barrier	6
Cognitive impairment in the HTLV-1 infection: a comparative study associated with functional performance	6
HSV-1 infection and pathogenesis in the tree shrew eye following corneal inoculation	6
The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women	6
Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeut	6
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus	5
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro	5
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV	5
Delayed post-hypoxic leukoencephalopathy in an adult with COVID-19	5
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage	5
Covid-19 post-infectious acute transverse myelitis responsive to corticosteroid therapy: report of two clinical cases	5
Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes	5
The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV	5
Typical gene expression profile of pseudorabies virus reactivation from latency in swine trigeminal ganglion	5
Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy	5
CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study	5
Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases	5
Peripheral blood lymphocyte proviral DNA predicts neurocognitive impairment in clade C HIV	5
Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder	4
Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads	4
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients	4
HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment	4
Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome	4
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis	4
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases	4
West Nile virus neuroinvasive disease associated with rituximab therapy	4
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers	4
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia	4
Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine	4
Main lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in HIV-1 subtypes C and B	3
Multi-functional auto-fluorescent nanogels for theranostics	3
Transcriptional signatures of Zika virus infection in astrocytes	3
Susac syndrome complicating a SARS-CoV-2 infection	3
Metagenomic next-generation sequencing of viruses, bacteria, and fungi in the epineurium of the facial nerve with Bell’s palsy patients	3
Acute vestibular neuritis: A rare complication after the adenoviral vector-based COVID-19 vaccine	3
Encephalopathy associated with COVID-19 in a patient with multiple sclerosis	3
Associations of alcohol use, HIV infection, and age with brain white matter microstructure	3
MicroRNA expression profiling of cerebrospinal fluid/serum exosomes in children with human herpesvirus 6-associated encephalitis/encephalopathy by high-throughput sequencing	3
A comprehensive data-driven analysis framework for detecting impairments in brain function networks with resting state fMRI in HIV-infected individuals on cART	3
Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances	3
Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other’s course?	3
The prevalence and outcomes of depression in older HIV-positive adults in Northern Tanzania: a longitudinal study	3

Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women	3
Dengue fever presenting as acute cerebellar ataxia: Case report and literature review	3
Plasma anti-CD4 IgG is associated with brain abnormalities in people with HIV on antiretroviral therapy	3
A fulminant case of Epstein-Barr Virus encephalitis with multiorgan dysfunction	3
Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies	3
Expression of TSLC1 in patients with HAM/TSP	3
Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature	3
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid	3
The impacts of HIV infection, age, and education on functional brain networks in adults with HIV	3
Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31	3
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections	3
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients	2
Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient	2
Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases	2
Effects of unhealthy alcohol use on brain morphometry and neurocognitive function among people with HIV	2
Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV?	2
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma	2
Microglia proliferation underlies synaptic dysfunction in the prefrontal cortex: implications for the pathogenesis of HIV-1-associated neurocognitive and affective alterations	2
Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy	2
Central nervous system reactivation of herpesviridae family in patients with COVID-19	2
Neurological soft signs and brain morphology in people living with HIV	2
Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model	2
How an increase in the copy number of HSV-1 during latency can cause Alzheimer’s disease: the viral and cellular dynamics according to the microcompetition model	2
Cytomegalovirus optic neuropathy in a young immunocompetent patient	2
Pre-clinical atherosclerosis is found at post-mortem, in the brains of men with HIV	2
Amebic infections of the central nervous system	2
Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study	2
Long-term sequelae of herpes simplex virus encephalitis–related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging	2
Effectiveness of virtual reality games for falls, postural oscillations, pain and quality of life of individual HAM/TSP: a randomized, controlled, clinical trial	2
Extensive longitudinal myelitis due to cytomegalovirus infection	2
Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV	2
Monkeypox virus replication underlying circadian rhythm networks	2
Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis	2
Herpes zoster preceding neuromyelitis optica spectrum disorder: casual or causal relationship? A systematic literature review	2
Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity	2
Human cytomegalovirus DNA detection in a recurrent glioblastoma multiforme tumour, but not in whole blood: a case report and discussion about the HCMV latency and therapy perspectives	2
Characteristics of taste dysfunction in COVID-19 subjects coming from two different countries	2
Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling	2
Rabies virus glycoprotein enhances spatial memory via the PDZ binding motif	2
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab	2
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV	2
Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda	2
Correction to: A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders	2
Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants	2
Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses	2
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD4	2
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology	2
Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy	2
Risk factors for neurological complications in children with Flavivirus infection	2
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis	2
A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry	2
HIV peripheral neuropathy‐related degeneration of white matter tracts to sensorimotor cortex	2
Disseminated cortical and subcortical lesions in neonatal enterovirus 71 encephalitis	2
A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient	2
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases	2
Influenza vaccination status in multiple sclerosis patients from Latin America	2
Interaction of declined handgrip strength and HIV infection on neurocognitive impairment	2